THE CHALLENGE OF METABOLIC CONTROL IN CONGENITAL GENERALISED LIPODYSTROPHY TYPE 2 (BERARDINELLI-SEIP SYNDROME)

Authors

  • Silvester Wei Teng Ngiaw
  • Hooi Peng Cheng

Keywords:

LIPODYSTROPHY, BERARDINELLI, SEIP, T2DM

Abstract

INTRODUCTION
Berardinelli-Seip congenital lipodystrophy (BSCL) is a heterogeneous autosomal recessive disorder characterised by an almost total lack of adipose tissue in the body, associated with the progressive development of metabolic complications. There are four different subtypes (I to IV) resulting from mutations in AGPAT2, BSCL2, CAV1 and PTRF genes, respectively. We investigated the characteristics of BSCL2 variants in Sarawak patients.

METHODOLOGY
The clinical features and laboratory indices were obtained by medical interview and medical records review.

RESULT
Patient 1 was a 19-year-old female diagnosed with lipodystrophy at 5 months, developed dyslipidaemia at 2 years and type 2 diabetes mellitus (T2DM) at 7 years. Her diabetes was difficult to control with metformin and insulin, as evidenced by progressive worsening of HbA1c from 7.4% to 12.1%. Patient 2 was a 13-year-old male, the younger brother of patient 1. He had dyslipidaemia and T2DM detected at 7 years. Glycaemic control was suboptimal with metformin and insulin, with HbA1c ranging from 9.8% to 14.7%. Subcutaneous premixed human insulin was the initial insulin of choice due to its ease of administration. Inevitably, both progressed to diabetic nephropathy and fatty liver. Recent efforts to intensify glycaemic control with basal-bolus insulin regimen were deemed promising. Patient 3 was a 7-year-old female who had T2DM at three years. Dyslipidaemia was apparent at one year of age. Patient 4 was a 3-year-old female, the sibling of patient 3. She had not developed any metabolic complications and was under close surveillance. Parental consanguinity was identified. All four patients resided in the same village. All of them exhibited a novel homozygous duplication mutation of c.567_573+1dupGAACTCGG.p. in intron 5.

CONCLUSION
The onset of metabolic complications occurs early in the first decade of life in BSCL. Optimal metabolic control is challenging in this condition.

Downloads

Download data is not yet available.

Author Biographies

Silvester Wei Teng Ngiaw

Paediatric Endocrine Unit, Sarawak General Hospital, Malaysia

Hooi Peng Cheng

Paediatric Endocrine Unit, Sarawak General Hospital, Malaysia

References

*

Downloads

Published

2024-07-17

How to Cite

Ngiaw, S. W. T., & Cheng, . H. P. (2024). THE CHALLENGE OF METABOLIC CONTROL IN CONGENITAL GENERALISED LIPODYSTROPHY TYPE 2 (BERARDINELLI-SEIP SYNDROME). Journal of the ASEAN Federation of Endocrine Societies, 39(S1), 129. Retrieved from https://asean-endocrinejournal.org/index.php/JAFES/article/view/4837

Issue

Section

Abstracts for Poster Presentation | Paediatric

Similar Articles

<< < 8 9 10 11 12 13 14 15 16 17 18 19 > >> 

You may also start an advanced similarity search for this article.